More Genetic Clues Needed to Improve Lung Cancer Treatment

Article

David Spigel, a lung cancer specialist, explains the potential of biomarkers in the search for new treatments.

David Spigel, director of the Lung Cancer Research Program at Sarah Cannon Research Institute in Nashville, answers CURE's questions on how biomarkers will affect lung cancer treatment now and in the future.

Podcast: David Spigel and the future of lung cancer biomarkers

While only a fraction of lung cancer mutations have a treatment that targets them, Spigel expects that in the near future, many more genetic clues will be uncovered. These discoveries will help shape treatment decisions for a wider range of patients.

Related Videos
Image of a man with rectangular glasses and short dark hair.
Image of a woman with long dark hair.
Image of Kristen Dahlgren at Extraordinary Healer.
Image of a woman with short blonde hair wearing a white blazer.
Image of a woman with black hair.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Sue Friedman in an interview with CURE
Catrina Crutcher in an interview with CURE
Related Content